Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
For context, the FDA-approved finished drug versions of semaglutide include brand names like Ozempic and Wegovy (registered trademarks of Novo Nordisk), and the FDA-approved finished drug versions of tirzepatide include Zepbound and Mounjaro (registered trademarks of Eli Lilly)
With this, P3 can design a custom treatment planwhich can include peptide therapythat brings your whole person into better health
Wegovy is indicated for people ages 12 years and older who have: A BMI of 30 kg/m 2 or higher A BMI of 27 kg/m 2 to 29.9 kg/m 2 and at least one weight-related comorbidity , such as high blood pressure, type 2 diabetes, or obstructive sleep apnea Wegovy is also indicated to reduce the risk of major cardiovascular events , such as heart attack or stroke, in people who have obesity or overweight
Retatrutide activates three hormone receptors (GLP-1, GIP, and glucagon) while tirzepatide activates two (GLP-1 and GIP)
US$ 21.12
US$ 27.17
US$ 29.83
US$ 26.41
US$ 29.65
US$ 23.04
US$ 28.75
US$ 23.04
US$ 28.30
